VNDA Vanda Pharmaceuticals Inc.

4.560USD+0.89%Mkt Cap: 275.71M $P/E: —

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for…

Key Statistics

Company
Market Cap275.71M USD
Enterprise Value126.09M USD
Revenue (TTM)215.72M USD
Gross Profit203.06M USD
Net Income (TTM)-220.47M USD
Revenue/Share3.63 USD
Last Price4.560 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees533
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)22.60
PEG2.23
EV/EBITDA-0.71
EV/Revenue0.58
P/S1.27
P/B0.97
EPS (TTM)-4.63
EPS (Forward)0.20
52W Range
4.2705% of range9.940
52W High9.940 USD
52W Low4.270 USD
Profitability
Gross Margin93.96%
Oper. Margin-126.28%
EBITDA Margin-82.07%
Profit Margin-102.02%
ROE-67.38%
ROA-45.09%
Growth
Revenue Growth-3.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-109.44M USD
CapEx (TTM)998.00K USD
FCF Margin-40.20%
FCF Yield-31.45%
Net Debt-147.20M USD
Net Debt/EBITDA0.83
Balance Sheet
Debt/Equity0.04
Current Ratio1.61
Quick Ratio1.40
Book Value/Sh4.67 USD
Cash/Share2.81 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.75 USD
Upside (mean)+157.7%
Target Range5.750 USD – 20.00 USD
5.750+157.7% to mean20.00
# Analysts5
Ownership
Shares Out.60.46M
Float47.66M
Insiders6.78%
Institutions86.45%
Short Interest
Short Ratio11.3d
Short % Float14.75%
Short % Out.14.05%
Shares Short8.50M
Short (prev mo.)7.67M
Technical
SMA 505.155 (-11.5%)
SMA 2006.510 (-30.0%)
Beta0.69
S&P 52W Chg16.45%
Avg Vol (30d)930.80K
Avg Vol (10d)1.44M
Technical Indicators
RSI (14)33.8
MACD-0.1831
MACD Signal-0.1303
MACD Hist.-0.0528
BB Upper5.512 USD
BB Middle4.995 USD
BB Lower4.479 USD
BB Width20.66%
ATR (14)0.2029 USD
Vol Ratio (20d)0.74x